The following is a summary of “Response to initial treatment with glucocorticoids in TAFRO syndrome and implications for ...

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate ...

Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...

Muscle mass plays a crucial role in overall health, strength, and metabolic function, making its regulation essential for maintaining quality of life. A re | Cell And Molecular Biology ...

Age and hypertension are associated with increased risks for cranial ischemic complications in GCA, while anticoagulant therapy may offer protective benefits.

with glucocorticoid-dependent PMR who experienced at least two PMR flares while glucocorticoids were being tapered. Patients were randomly assigned to receive either a placebo (n = 50) or ABBV-154 ...

Roche has reported positive results from its Phase III REGENCY trial of Gazyva (obinutuzumab) for the treatment of lupus ...

Patients with late-onset rheumatoid arthritis experienced greater functional impairment over 5 years, compared against those with younger-onset disease.

The more time alpha males spend guarding mates, the higher their stress hormones rise and the more their energy reserves ...

While Roche’s Gazyva has been on the market for a dozen years and has won four approvals from the FDA, it is making a late ...

The researchers note that TSW was defined as dependence on topical glucocorticoids (TGCs) and adverse reactions to their use. The most reported signs were erythema, desquamation, dryness, and oozing ...